Member Info for Thelix

Halifax "regrettably" do not give out physical shares or matched shares so I have abaco in my account but no OPL's. So basically I have lost my holding in the OXPZero tech which looks like it may still be commerciable as FDA have allowed them another route to sale, but I have gained a holding in a cash shell which if it doesnt succeed after 6 months goes away. So basically I have lost everything I invested in OXP. Cool. And people here said the demerger was a good thing.

I get it. The company is now a nonlisted private company making those chew vitamins and chugging along. We get a representative amount of shares from the OXP holdings that will be directly influenced or matching the capital/assets (19.3 mil £) which can be traded via a matched settlement facility. This cash shell holds all propriety and patented techs for OXPZero in the event it can launch them. In the meantime an RTO required within 6 months and if it doesnt it has a 6 month window on top to either return to market or be caput, or get an RTO in place. I still dont see how the demerger helps other than clawing back cash value matched settlement over market sentiment as thr mcap was lower than cash. Well the FDA seemed happy with another viable option so I assume OXPZero is still background wise being sorted but they need another vehicle to RTO to get out of muddy waters. Surely if more headway is made with FDA this can simply remerger and return? I am wondering if this is a stall tactic and is simply being exercised to cool off 12 months of market nonsense...

My OXP shares are nonexistent - I only hold OPL abaco capital shares. I am with Halifax and they do not allow trading off platform - even with a willing buyer! They simply do not support that service. Secondly the corporate action notice stated you can have a matched bargain settlement - so they "promise" to match its price based on OXP shares here? The RNS seemed quite simple - my account however shows a significant since the demerger and NO OXP shares. I am certain the RNS stated we get to have both... My account only has abaco shares...Other people seem to hold both entities -are there any other Halifax users here who could shed some light on this matter?

That sucks. I now only hold OPL shares -I thought this was being split? Also as OPL shares are not being listed they cannot be bought and sold etc. So basically, the fat lady has sang. The wording suggested as if we keep a % of shares based on the financial split of the companies total assetts.

Get corporate action notice? 20th today is when everything should be made effective and 29th the shares get listed. The OPL shares wont be listed on an exchange apparently?

Looking good for a nice placement price. This is a good one to trade on. Always bottoms to 0.1p, always rockets to 0.2-0.4p for placement salary,and back to 0.1p again. Look at the charts. Clockwork.

valued at zero because there are none. The 2nd to last RNS clearly states the board is looking for development elsewhere. There is no lithium on what they bought.

Just stop. You dont know what youre talking about.

strong base? lol this was "safe" at 1.5p. "rock bottom" at 0.8p, and now has a strong base at 0.25p LOL. This is on its way out entirely and good riddance.

2020 is quite soon for pharma. GWP went from 100mil mcap to 2.5 bil on phase 2 readout and eventual phase 3. They wont be commercial for a while yet too. Phase 2 end point being positive is usually the signal for further gains - then again NASDAQ launches usually are and this one flopped.

It doesnt matter how cheap the drills are - no lithium is there and this is dead.

So considering an RNS landed saying OXP (as it is currently known) can have a US OTC launch (the easiest and most profitable one) on a phase I trial the rise was tiny today. So. Why? Two options from where I can see. 1. Market will pick up over next few days. 2. So, this split - its solely due to launching being incapable (until todays RNS) and the plan is to have a ~20 mil cash shell and a pharma company with ~1 mil to launch a product. The issue here is a cash shell is worth...the cash...The pharma company with only 1 mil will be worth...3x cash - maybe 5 as it has "future capability" So we have 1.6p per share for the 20 mil and assuming same figures for OPL (which they said is the case) about 0.25p per share max totalling 1.85p. Now this was once worth north of �250 mil mcap as it had a lot of cash (25 mil) and a stream of lucrative pipeline products. The separation and cash shell was a strategy to recover losses of basically "no commercial capability". That commercial capability is back on the table and OXP/OPL need that cash to further that launch. They raised exactly that cash as they knew the cost to market this. So unless they cant backpedal we will have a company with a viable product strapped of the cash it needs, and a cash shell investing in some random company "preferably pharma as thats what the directorate know". I think that is the reason the SP hasnt lifted much.I hope they can backtrack the shell strategy.

Phat - Welcome to AIM, while I agree - the market does not. The falls never recover well even if you are in an identical situation before the fall. This should be north of 2p soon however.

VERY good news. Kind of defeats the entire point of the demerger really. Looks as if US OTC is back on track. VERY weird-looks like FDA played hard ball over the top first time round. This may well rebound massively now - one in a thousand AIM rebound and I sold it last week oh well lol.

By waiting the sp will decline further. This is going in one direction and only one direction. I have sold and been trading the liquid cash and already made back my loss here - sitting on a paper loss with a 1% chance of a turnaround is a terrible strategy but end of the day the decision is with the one pressing sell.

by PI boredom selling? Nah - somethings going on here.

has been the worst nasdaq listing I have ever seen and this price fall is not people selling. Weve had �45k worth of share sells wipe �30 million off the mcap. Trial data has been leaked or previewed I reckon (Just my view).

incoming. The BoD here are useless.

going sub 1p. A declining SP with a trial 75% completed suggests a leak, and not a good one. Hope they make the endpoints with 554 or game over

OXPZero is very viable as a product -the issue is the board seem reluctant to follow basic pharma industry guidelines with which all other companies adhere to. The mcap will now be 1.3 million as that is cash levels -maybe a bit more, so sub 1 penny blatantly coming. The RTO will benefit the holders of the company they eventually take over - not us or our shares. The fat lady has sang. It is over. Sold up already.